Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;3(6):387-393.
doi: 10.1016/j.jpha.2013.03.001. Epub 2013 Mar 20.

Pharmacokinetic study of inosiplex tablets in healthy Chinese volunteers by hyphenated HPLC and tandem MS techniques

Mo Chen  1 , Yuan Zhang  1 , Xiao-Ting Que  1 , Ya Ding  1 , Lin Yang  2 , Ai-Dong Wen  2 , Tai-Jun Hang  1
Affiliations

Pharmacokinetic study of inosiplex tablets in healthy Chinese volunteers by hyphenated HPLC and tandem MS techniques

Mo Chen et al. J Pharm Anal. 2013 Dec.

Abstract

Inosiplex is a compound formulation composed of inosine and p-acetaminobenzoic acid (PABA) salt of N,N-dimethylamino-2-propanol (DIP). This study was to investigate the clinical plasma pharmacokinetic properties of DIP and PABA after single and multiple oral doses of inosiplex tablets in healthy Chinese volunteers. The established LC/MS/MS method for plasma DIP determination had a linear range of 0.02-10 µg/mL, and the HPLC method for plasma PABA determination had a linear range of 0.05-40 µg/mL. Linear pharmacokinetic characteristics were found with single oral doses of 0.5, 1.0 and 2.0 g. No obvious accumulation effects were observed for DIP and PABA.

Keywords: HPLC; Inosiplex; LC/MS/MS; N,N-dimethylamino-2-propanol; Pharmacokinetics; p-Acetaminobenzoic acid.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Chemical structures of (A) inosiplex, (B) amantadine (internal standard for DIP), and (C) paracetamol (internal standard for PABA).
Fig. 2
Fig. 2
Product ions spectra of (A) DIP and (B) amantadine.
Fig. 3
Fig. 3
Typical MRM chromatograms of DIP and IS (amantadine) in human plasma. (A) Blank plasma sample; (B) plasma sample spiked with 10.0 μg/mL DIP and 4.00 μg/mL amantadine (IS); and (C) plasma sample 4 h after an oral administration of 1.0 g inosiplex tablets to a volunteer (DIP 1.01 μg/mL and amantadine 4.00 μg/mL).
Fig. 4
Fig. 4
Typical chromatograms of PABA and IS (paracetamol) in human plasma. (A) Drug-free plasma sample; (B) plasma sample spiked with PABA (tR=7.7 min, C=1.00 μg/mL) and IS (paracetamol, tR=5.5 min, C=5.00 μg/mL); and (C) plasma obtained from a volunteer at 0.5 h after oral administration of 0.5 g inosiplex with PABA (tR=7.7 min, C=2.22 μg/mL) and IS (paracetamol, tR=5.5 min, C=5.00 μg/mL).
Fig. 5
Fig. 5
The mean plasma concentration–time profiles of (A) DIP and (B) PABA in healthy volunteers (n=10) after a single oral administration of 0.5, 1.0, and 2.0 g and multiple oral doses of 1.0 g inosiplex tablets.
None
See this image and copyright information in PMC

References

    1. Morin A., Ballet J.J. A recent overview on in vitro and in vivo immunological activities of methisoprinol. Allergol. Immunopath. 1982;10:109–114. - PubMed
    1. Gascon G.G. Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study. J. Child Neurol. 2003;18(12):819–827. - PubMed
    1. Tay S.K. Efficacy of inosine pranobex oral therapy in subclinical human papillomavirus infection of the vulva: a randomized double-blinded placebo controlled study. Int. J. STD AIDS. 1996;7:276–280. - PubMed
    1. Georgala S., Katoulis A., Befon A. Oral inosiplex in the treatment of cervical condylomata acuminata: a randomized placebo-controlled trial. BJOG. 2006;113:1088–1091. - PubMed
    1. Simone C.De, Famularo G., Tzantzoglou S. Inosine pranobex in the treatment of HIV infection: a review. Int. J. Immunopharmacol. 1991;13(Suppl. 1):S19–S27. - PubMed

LinkOut - more resources